inn

(redirected from Bortezomib)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.

inn

see HOTEL.

INN. A house where a traveller is furnished with every thing he has occasion for while on his way. Bac. Ab. Inns. B; 12 Mod. 255; 3 B. & A. 283; 4 Campb. 77; 2 Chit. Rep. 484; 3 Chit. Com. Law, 365, n. 6.
     2. All travellers have a lawful right to enter an inn for the purpose of being accommodated. It has been held that an innkeeper in a town through which lines of stages pass, has no right to, exclude the driver of one of these lines from his yard and the common public rooms, where travellers are usually placed, who comes there at proper hours, and in a proper manner, to solicit passengers for his coach, and without doing any injury to the innkeeper. 8 N. H. R. 523; Hamm. N. P. 170. Vide Entry; Guest.

References in periodicals archive ?
This is the largest systematic analysis of the bortezomib treatment in MM patients with HBV in China to date.
Cyclophosphamide and dexamethasone (CD) was commenced 6 months post-transplantation; however, disease progression continued and 2 years post ASCT bortezomib monotherapy was started at the dose of 1.
To make this discovery, scientists used two groups of mice-the first treated with bortezomib and the second with saline.
Patients should not receive VELCADE if they are allergic to bortezomib, boron or mannitol.
Presently, the product is indicated for use in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy; and as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, whose prior therapy included a PI and an immunomodulatory agent, and who have demonstrated disease progression on the last therapy.
The early stage trial combined elotuzumab with bortezomib, or Velcade, one of the novel chemotherapies approved to treat multiple myeloma, a cancer that arises in the plasma cells.
The MMRC is particularly excited about this trial because data presented at the recent American Society of Hematology Annual Meeting demonstrated that combining histone deacetylase inhibitors, such as vorinostat, with the proteasome inhibitor, bortezomib, may help to overcome prior resistance to bortezomib.
Myeloma - Therapy, excluding Transplantation: Poster III Abstract #: 4061 Title: Rocilinostat (ACY-1215), a Selective HDAC6 Inhibitor, Alone and in Combination with Bortezomib in Multiple Myeloma: Preliminary Results from the First-in-Humans Phase I/II Study Authors Affiliated with the Following Institutions: Massachusetts General Hospital, Medical College of Wisconsin, University of Pennsylvania Perelman School of Medicine, Mount Sinai School of Medicine, University of Texas MD Anderson Cancer Center, Harvard Medical School, Rho Inc, Emory University and Acetylon Pharmaceuticals Inc.
Via the US FDA application, the company seeks to expand the current indication, using DARZALEX in combination with bortezomib (a proteasome inhibitor [PI]), melphalan and prednisone, for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation (ASCT).
This application seeks to broaden the existing marketing authorization for daratumumab to include use in combination with bortezomib, melphalan and prednisone, for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.
3 It received additional approvals in November 2016 in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.
Genmab said this application seeks to broaden the existing marketing authorisation for daratumumab (DARZALEX) to include use in combination with bortezomib, melphalan and prednisone, for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant (ASCT).